[Research Report] The image guided radiotherapy market size is projected to surge from US$ 1,814.25 million in 2022 to US$ 5,650.72 million by 2030; the market is estimated to grow at a CAGR of 15.3% during 2022–2030.
Analyst Perspective:
The image-guided radiation therapy market is poised to witness remarkable growth and transformation, driven by cutting-edge technological advances and the growing importance of personalized cancer treatment. Image-guided radiation therapy, with its precise targeting of tumors using real-time imaging, plays a critical role in minimizing radiation exposure to healthy tissue, thereby reducing side effects and improving patient outcomes. By bringing together artificial intelligence (AI) and machine learning (ML) algorithms, image-guided radiation therapy systems have become even more sophisticated, allowing oncologists to tailor radiation therapy plans to individual patient needs with unprecedented accuracy. In addition, the accessibility and affordability of image-guided radiation therapy are expected to increase, ensuring that more patients can benefit from this revolutionary approach to treating cancer, ultimately leading to higher survival rates and improved quality of life for those suffering from cancer.
Market Overview:
Radiation therapy is a local treatment used to treat cancer cells with ionizing radiation. Image-guided radiation therapy is the method of using periodic two- and three-dimensional imaging during radiation treatment to guide radiation therapy based on the image coordinates of the actual radiation treatment plan. Image-guided radiation therapy can help make surgeries less invasive and precise, resulting in shorter hospital stays and fewer procedures. Image-guided radiation therapy is the most advanced technology for tracking cancer and sparing normal tissue. The technology is one of the most efficient types of radiation therapy, reducing the radiation dose to normal tissue, reducing side effects, and improving outcomes.
The growth of the image-guided radiation therapy market is driven by synergistic factors, including robust healthcare infrastructure, increasing cancer prevalence, conducive reimbursement policies, technological innovations, active research initiatives, well-defined regulatory frameworks, and rising adoption of minimally invasive procedures. Continuous technological advances, greater emphasis on non-invasive cancer interventions, and a supportive healthcare ecosystem are expected to sustain this upward trend.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Image Guided Radiotherapy Market: Strategic Insights
Market Size Value in US$ 1,814.25 million in 2022 Market Size Value by US$ 5,650.72 million by 2030 Growth rate CAGR of 15.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Image Guided Radiotherapy Market: Strategic Insights
| Market Size Value in | US$ 1,814.25 million in 2022 |
| Market Size Value by | US$ 5,650.72 million by 2030 |
| Growth rate | CAGR of 15.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Rising Prevalence of Cancer Worldwide Drive Global Image Guided Radiotherapy Market
Health systems across the globe are witnessing a substantial increase in the prevalence of cancer. According to the World Health Organization (WHO), in 2019, ~9.6 million deaths were due to cancer across the globe. According to the same source, colorectal, liver, prostate, lung, and stomach cancer are most observed in men, while breast, colorectal, and cervical cancer are the most common among women.
According to Cancer Research UK, in 2020, ~0.16 million people in the UK die each year due to cancer. Cancer is one of the leading reasons of death globally, causing ~10 million deaths in 2020, according to the WHO. The most common forms of cancer in 2020 were breast cancer (2.26 million cases) and lung cancer (2.21 million cases). According to the American Cancer Society, the burden of cancer worldwide is expected to reach ~28.4 million cases by 2040, increased by 47% from 2020, with greater increases in developing countries due to demographic changes. However, this is further compounded by increasing risk factors that can be exacerbated by globalization and a growing economy. The Global Cancer Observatory (GLOBOCAN) estimates that there were 19.3 million cases of cancer worldwide in 2020. GLOBOCAN predicted that cancer cases in India would rise to 2.08 million in 2040 compared to 2020, an increase of 57.5%. According to WHO, nearly 2.3 million women worldwide were detected with breast cancer, and ~685,000 deaths were registered due to the same in 2020. According to Advocate Health Care, over 60% of cancer patients undergo some form of radiation therapy as part of their treatment. This is because radiation therapy is very effective in fighting several types of cancer as it destroys the cancer cell's ability to reproduce. Image guided radiotherapy allows the radiation therapist to locate the target area better and direct the beam of radiation at the tumor immediately before or even during treatment. Thus, the high prevalence of cancer is anticipated to drive the adoption of image guided radiotherapy.
According to data published by the WHO in March 2021, over 50% of cancer patients involve radiotherapy as part of cancer management and care. Moreover, according to the same data, radiotherapy is prominently used to treat the most common types of cancer, such as colorectal, lung, breast, and cervical cancer. From the patient's point of view, early detection and diagnosis can prevent unnecessary pain and suffering. It can also reduce the scale and cost of treatment. Further, government awareness will propel the market. For instance, Public Health England, in partnership with the Department of Health and NHS England, leads the “Be Clear on Cancer” program. The program aims to improve early diagnosis of cancer by increasing public awareness of the signs and symptoms of cancer and further urging people to see their doctors without delay.
Segmental Analysis:
Based on type, the image guided radiotherapy market is segmented into product and services. The product segment held the largest market share in 2022. services segment is anticipated to register the highest CAGR of 15.5% during 2022–2030. The Increasing awareness about radiation therapy has increased the demand of radiotherapy equipment such as linear accelerators (LINAC) and MRI- LINAC which helps in delivering the therapy to large patient population. Moreover, there has been tremendous growth in oncology centers which has further generated the demand for radiotherapy equipment which in turn driving the product segment and contributing the image guided radiotherapy market growth.
Based on application, the image guided radiotherapy market is segmented into breast cancer, lung cancer, gastrointestinal cancer, prostate cancer, gynecological cancers, head and neck cancer, and others. The breast cancer segment held the largest market share in 2022. The lung cancer segment is anticipated to register the highest CAGR of 16.3% during 2022–2030.
Based on imaging type, the image guided radiotherapy market is segmented into magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) imaging, and others. The magnetic resonance imaging (MRI) segment held the largest market share in 2022. The computed tomography (CT) imaging segment is anticipated to register the highest CAGR of 15.8% from 2022 to 2030.
Based on end user, the image guided radiotherapy market is segmented into hospitals, oncology centers, and radiotherapy centers. The hospitals segment held the largest market share in 2022. The oncology centers segment is anticipated to register the highest CAGR of 16.0% during 2022–2030.
Regional Analysis:
North America dominates the image guided radiotherapy market. The North America image guided radiotherapy market was valued at US$ 760.70 million in 2022 and is projected to reach US$ 2,409.12 million by 2030; it is expected to register a CAGR of 15.5% during 2022–2030. The North America image guided radiotherapy market is segmented into the US, Canada, and Mexico. North America has an advanced healthcare infrastructure that is due to a higher incidence of cancer. In North America, a sophisticated healthcare infrastructure coupled with easy access to state-of-the-art medical technologies creates a favorable environment for the integration of advanced treatment modalities, such as image-guided radiation therapy. The region's particularly comprehensive healthcare reimbursement frameworks are increasing the uptake of sophisticated treatments, including image-guided radiation therapy, ensuring they are accessible to a wider range of patients. This confluence of factors underpins the impetus for expanding and strengthening the image-guided radiotherapy market.
The Europe image-guided radiotherapy market is expected to grow substantially during the forecast period owing to the availability of advanced treatment facilities, qualified medical professionals, and government support for research and development. Asia Pacific is the fastest-growing market due to increasing cancer prevalence, growing cancer awareness, and availability of new treatments.
Image Guided Radiotherapy Market Report Scope
Key Player Analysis:
ViewRay, GE Healthcare, Hitachi, Ltd.; Siemens AG, Koninklijke Philips N.V.; TOSHIBA CORPORATION, Varian Medical Systems, Inc.; Vision RT Ltd.; Elekta AB, Accuray Incorporated, and HORIBA Group are among the key players analyzed during the image guided radiotherapy market study.
Recent Developments:
The companies operating in the image guided radiotherapy market highly adopt inorganic and organic strategies such as mergers and acquisitions. A few of the recent market developments are listed below:
- In May 2023, Philips expanded its mobile C-arm portfolio with Zenition 10.
- In April 2023, GE HealthCare expanded its portfolio of magnetic resonance imaging (MRI) contrast agents with the launch of Pixxoscan. It provides customers with access to two leading macrocyclic molecules: Clariscan (gadoteric acid) and Pixxoscan (gadobutrol).
- In June 2023, GE HealthCare announced its plans to expand its PET/MR capabilities with AIR technologies to improve diagnostic precision and simplify treatment evaluation while increasing patient comfort.
- In September 2022, China's regulatory authority, the National Medical Products Administration (NMPA), approved the sale and use of ViewRay's MRIdian MRI-guided radiation therapy system.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, Imaging Type, End Users, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the growth of the image guided radiotherapy market include the rising prevalence of cancer worldwide and the introduction of technologically advanced systems.
The image guided radiotherapy market majorly consists of the players such as ViewRay, GE Healthcare, Hitachi, Ltd.; Siemens AG, Koninklijke Philips N.V.; TOSHIBA CORPORATION, Varian Medical Systems, Inc.; Vision RT Ltd.; Elekta AB, Accuray Incorporated, and HORIBA Group.
Radiation therapy is a local treatment used to treat cancer cells with ionizing radiation. Image-guided radiation therapy is the method of using periodic two- and three-dimensional imaging during radiation treatment to guide radiation therapy based on the image coordinates of the actual radiation treatment plan. Image-guided radiation therapy can help make surgeries less invasive and precise, resulting in shorter hospital stays and fewer procedures. Image-guided radiation therapy is the most advanced technology for tracking cancer and sparing normal tissue. The technology is one of the most efficient types of radiation therapy, reducing the radiation dose to normal tissue, reducing side effects, and improving outcomes.
The global image guided radiotherapy market, based on therapy type is segmented product and services. The product segment held the largest market share in 2022. The proton beam therapy segment is anticipated to register the highest CAGR of 15.5% during 2022–2030. Based on application, the image guided radiotherapy market is segmented into breast cancer, lung cancer, gastrointestinal cancer, prostate cancer, gynecological cancers, head and neck cancer, and others. The breast cancer segment held the largest market share in 2022. The lung cancer segment is anticipated to register the highest CAGR of 16.3% during 2022–2030. Based on imaging type, the image guided radiotherapy market is segmented into magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) imaging, and others. The magnetic resonance imaging (MRI) segment held the largest market share in 2022. The computed tomography (CT) imaging segment is anticipated to register the highest CAGR of 15.8% from 2022 to 2030. The image guided radiotherapy market, based on end user is segmented into hospitals, oncology centers, and radiotherapy centers. The hospitals segment held the largest market share in 2022. The oncology centers segment is anticipated to register the highest CAGR of 16.0% during 2022–2030.
The image guided radiotherapy market is expected to be valued at US$ 5,650.72million in 2030.
The image guided radiotherapy market was valued at US$ 1,814.25 million in 2022.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Image Guided Radiotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Image Guided Radiotherapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Image Guided Radiotherapy Market - Global Market Analysis
6.1 Image Guided Radiotherapy - Global Market Overview
6.2 Image Guided Radiotherapy - Global Market and Forecast to 2030
7. Image Guided Radiotherapy Market – Revenue Analysis (USD Million) – By Type, 2020-2030
7.1 Overview
7.2 Product
7.3 Services
8. Image Guided Radiotherapy Market – Revenue Analysis (USD Million) – By Application, 2020-2030
8.1 Overview
8.2 Breast Cancer
8.3 Lung Cancer
8.4 Prostate Cancer
8.5 Gastrointestinal Cancer
8.6 Gynecological Cancer
8.7 Head and Neck Cancer
8.8 Others
9. Image Guided Radiotherapy Market – Revenue Analysis (USD Million) – By Imaging Type, 2020-2030
9.1 Overview
9.2 Computed Tomography (CT)
9.3 Magnetic Resonance Imaging (MRI)
9.4 Positron Emission Tomography (PET)
9.5 Others
10. Image Guided Radiotherapy Market – Revenue Analysis (USD Million) – By End User, 2020-2030
10.1 Overview
10.2 Hospitals
10.3 Oncology Centers
10.4 Radiotherapy Centers
11. Image Guided Radiotherapy Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
11.1 North America
11.1.1 North America Image Guided Radiotherapy Market Overview
11.1.2 North America Image Guided Radiotherapy Market Revenue and Forecasts to 2030
11.1.3 North America Image Guided Radiotherapy Market Revenue and Forecasts and Analysis - By Type
11.1.4 North America Image Guided Radiotherapy Market Revenue and Forecasts and Analysis - By Application
11.1.5 North America Image Guided Radiotherapy Market Revenue and Forecasts and Analysis - By Imaging Type
11.1.6 North America Image Guided Radiotherapy Market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Image Guided Radiotherapy Market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Image Guided Radiotherapy Market
11.1.7.1.1 United States Image Guided Radiotherapy Market, by Type
11.1.7.1.2 United States Image Guided Radiotherapy Market, by Application
11.1.7.1.3 United States Image Guided Radiotherapy Market, by Imaging Type
11.1.7.1.4 United States Image Guided Radiotherapy Market, by End User
11.1.7.2 Canada Image Guided Radiotherapy Market
11.1.7.2.1 Canada Image Guided Radiotherapy Market, by Type
11.1.7.2.2 Canada Image Guided Radiotherapy Market, by Application
11.1.7.2.3 Canada Image Guided Radiotherapy Market, by Imaging Type
11.1.7.2.4 Canada Image Guided Radiotherapy Market, by End User
11.1.7.3 Mexico Image Guided Radiotherapy Market
11.1.7.3.1 Mexico Image Guided Radiotherapy Market, by Type
11.1.7.3.2 Mexico Image Guided Radiotherapy Market, by Application
11.1.7.3.3 Mexico Image Guided Radiotherapy Market, by Imaging Type
11.1.7.3.4 Mexico Image Guided Radiotherapy Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East and Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East and Africa
11.5 South and Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South and Central America
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Image Guided Radiotherapy Market - Key Company Profiles
14.1 ViewRay
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 GE Healthcare
14.3 Hitachi, Ltd.
14.4 Siemens AG
14.5 Koninklijke Philips N.V.
14.6 TOSHIBA CORPORATION
14.7 Varian Medical Systems, Inc.
14.8 Vision RT Ltd.
14.9 Elekta AB
14.10 Accuray Incorporated
14.11 HORIBA Group
15. Appendix
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
The List of Companies - Image Guided Radiotherapy Market
- ViewRay
- GE Healthcare
- Hitachi, Ltd.
- Siemens AG
- Koninklijke Philips N.V.
- TOSHIBA CORPORATION
- Varian Medical Systems, Inc.
- Vision RT Ltd.
- Elekta AB
- Accuray Incorporated
- HORIBA Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Image Guided Radiotherapy Market
Dec 2023
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Dec 2023
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Dec 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Dec 2023
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Dec 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Dec 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2023
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Dec 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For